Standard Contracts
PATENT & Technology LICENSE AGREEMENT AGT. No. A2013-2080Patent & Technology License Agreement • January 10th, 2014 • Microlin Bio, Inc. • Ohio
This Patent & Technology License Agreement is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).
MICROLIN BIO INC. NONQUALIFIED STOCK OPTION AGREEMENTNonqualified Stock Option Agreement • January 10th, 2014 • Microlin Bio, Inc. • Delaware
MicroLin Bio Inc., a Delaware corporation (the “Company”), grants to the Grantee named below, in accordance with the terms of the Microlin Bio Inc. Equity Incentive Plan (the “Plan”) and this Nonqualified Stock Option Agreement (this “Agreement”), an option (the “Stock Option”) to purchase the number of Shares at the exercise price per share (“Exercise Price”) as follows:
CONSULTING AGREEMENTConsulting Agreement • January 10th, 2014 • Microlin Bio, Inc. • New York
THIS CONSULTING AGREEMENT (the "Agreement") is made and entered into this day of December 30, 2013, (the "Effective Date") by and between Microlin Bio, Inc., a Delaware corporation duly organized under law and having an usual place of business at 302A W. 12th Street, Suite 114, New York, NY 10014 (hereinafter referred to as the “Company") and Jeffrey Jensen (hereinafter referred to as the "Consultant") residing at 716 La Canada St., La Jolla, CA 92037.
PATENT & Technology LICENSE AGREEMENT AGT. No. A2014-0294Patent & Technology License Agreement • January 10th, 2014 • Microlin Bio, Inc.
This Patent & Technology License Agreement is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).
MICROLIN BIO, INC. Scientific Advisory Board AgreementScientific Advisory Board Agreement • January 10th, 2014 • Microlin Bio, Inc. • New York
This Scientific Advisory Board Agreement (the “Agreement”) is made and entered into as of December 18, 2013 (the “Effective Date”), by and between Microlin Bio, Inc., a Delaware company, having its principal place of business at 302A W. 12th Street, NY, NY 10014 (the “Company”), and Dr. George Calin, an individual with an address at 1515 Holcombe Blvd., Unit 1950, Houston, TX 77030-4009 (the “Advisor”). The Company and the Advisor may be referred to herein individually as “Party” or collectively, as “Parties.”
MICROLIN BIO, INC. Scientific Advisory Board AgreementScientific Advisory Board Agreement • January 10th, 2014 • Microlin Bio, Inc. • New York
This Scientific Advisory Board Agreement (the “Agreement”) is made and entered into as of September 18, 2013 (the “Effective Date”), by and between MicroLin Bio, Inc., a Delaware company, having its principal place of business at 302A W. 12th Street, NY, NY 10014 (the “Company”), and Dr. Philip Tsichlis, an individual with an address at 25 Jefferson Road, Winchester MA, 01890 (the “Advisor”). The Company and the Advisor may be referred to herein individually as “Party” or collectively, as “Parties.”
MICROLIN BIO, INC. Scientific Advisory Board AgreementScientific Advisory Board Agreement • January 10th, 2014 • Microlin Bio, Inc. • New York
This Scientific Advisory Board Agreement (the “Agreement”) is made and entered into as of December 19, 2013 (the “Effective Date”), by and between MicroLin Bio, Inc., a Delaware company, having its principal place of business at 302A W. 12th Street, NY, NY 10014 (the “Company”), and Dr. Sakari Kauppinen, an individual with an address at Norskekrogen 12, DK-2765 Smoerum, Denmark (the “Advisor”). The Company and the Advisor may be referred to herein individually as “Party” or collectively, as “Parties.”
MICROLIN BIO INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • January 10th, 2014 • Microlin Bio, Inc. • Delaware
MicroLin Bio Inc., a Delaware corporation (the “Company”), grants to the Grantee named below, in accordance with the terms of the MicroLin Bio Inc. Equity Incentive Plan (the “Plan”) and this Incentive Stock Option Agreement (this “Agreement”), an option (the “Stock Option”) to purchase the number of Shares at the exercise price per share (“Exercise Price”) as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • January 10th, 2014 • Microlin Bio, Inc. • New York
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into by Microlin Bio, Inc., a Delaware corporation with its principal business address at 302A West 12th Street Suite 114 New York, NY 10014 (the “Company”), and Joseph Hernandez, an individual residing at 635 West 42nd Street Apt. 11K (the “Executive”) July 15th, 2013 (the “Commencement Date”).
MICROLIN BIO, INC. Scientific Advisory Board AgreementScientific Advisory Board Agreement • January 10th, 2014 • Microlin Bio, Inc. • New York
This Scientific Advisory Board Agreement (the “Agreement”) is made and entered into as of September 20, 2013 (the “Effective Date”), by and between MicroLin Bio, Inc., a Delaware company, having its principal place of business at 302A W. 12th Street, NY, NY 10014 (the “Company”), and Dr. Robert Lee, an individual with an address at 2300 Green Island Dr., Columbus, OH 43228 (the “Advisor”). The Company and the Advisor may be referred to herein individually as “Party” or collectively, as “Parties.”
FORM OF DIRECTOR INDEMNIFICATION AGREEMENTDirector Indemnification Agreement • January 10th, 2014 • Microlin Bio, Inc. • Delaware
THIS DIRECTOR INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into this ___ day of _______________, 20__, by and between Microlin Bio, Inc, a Delaware corporation (the “Corporation”), and _______________ (“Agent”).
MICROLIN BIO, INC. Scientific Advisory Board AgreementScientific Advisory Board Agreement • January 10th, 2014 • Microlin Bio, Inc. • New York
This Scientific Advisory Board Agreement (the “Agreement”) is made and entered into as of August 7, 2013 (the “Effective Date”), by and between MicroLin Bio, Inc., a Delaware company, having its principal place of business at 302A W. 12th Street, NY, NY 10014 (the “Company”), and Dr. Carlo Croce, an individual with an address at 2104 Cambridge Blvd, Columbus, OH 43221 (the “Advisor”). The Company and the Advisor may be referred to herein individually as “Party” or collectively, as “Parties.”
FORM OF OFFICER INDEMNIFICATION AGREEMENTOfficer Indemnification Agreement • January 10th, 2014 • Microlin Bio, Inc. • Delaware
THIS OFFICER INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into this ___ day of _______________, 20__, by and between Microlin Bio, Inc, a Delaware corporation (the “Corporation”), and _______________ (“Agent”).
ContractStock Option Agreement • January 10th, 2014 • Microlin Bio, Inc. • Delaware
THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS STOCK OPTION AGREEMENT AND THE SECURITIES UNDERLYING THIS STOCK OPTION AGREEMENT MAY NOT BE SOLD, PLEDGED, HYPOTHECATED, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS SUCH SALE, PLEDGE, HYPOTHECATION, TRANSFER OR OTHER DISPOSITION SHALL HAVE BEEN REGISTERED UNDER SAID ACT AND IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS OR UNTIL THE COMPANY SHALL HAVE RECEIVED A LEGAL OPINION SATISFACTORY IN FORM AND SUBSTANCE TO THE COMPANY, THAT SUCH SECURITIES MAY BE LEGALLY SOLD OR OTHERWISE TRANSFERRED WITHOUT SUCH REGISTRATION AND COMPLIANCE.
CONSULTING AGREEMENTConsulting Agreement • January 10th, 2014 • Microlin Bio, Inc. • New York
THIS CONSULTING AGREEMENT (the "Agreement") is made and entered into this day of November 22, 2013, (the "Effective Date") by and between Microlin Bio, Inc., a Delaware corporation duly organized under law and having an usual place of business at 302A W. 12th Street, Suite 114, New York, NY 10014 (hereinafter referred to as the “Company") and Eric G. Marcusson (hereinafter referred to as the "Consultant") residing at 260 King Street, Suite 727, San Francisco, CA 94107.
